Pharma Stocks
-
Stocks to Watch for June 4: Rajesh Exports, Aurobindo Pharma, IndiGo, NBCC and more
1 / 15 Aurobindo Pharma | The pharma company inaugurated TheraNym, a dedicated biologics contract manufacturing organisation (CMO), marking its…
Read More » -
Eli Lilly Just Proved Gene Editing Could Be Pharma’s Next Gold Rush — but CRISPR Therapeutics Investors Should Watch Out
Key Points Eli Lilly just posted encouraging results from a clinical trial for a gene-editing candidate. It could compete with…
Read More » -
Even If Eli Lilly Stock Continues to Shine, Stay Away from This Pharmaceutical ETF
A concept image of weight-loss pills and a measuring tape by Artem Stepanov via Shutterstock One of the biggest misconceptions…
Read More » -
Merck & Co Inc Stock (MRK) Moved Down by 3.19% on Jun 1: A Full Analysis
Merck & Co. experienced a downward movement in its share price, suggesting investors may be engaging in profit-taking or re-evaluating…
Read More » -
Spotting Winners: Bristol-Myers Squibb (NYSE:BMY) And Branded Pharmaceuticals Stocks In Q1
The end of the earnings season is always a good time to take a step back and see who shined…
Read More » -
Pankaj Pandey identifies defence, pharma and consumption as core stock picking themes
A potential monsoon deficit, mixed corporate earnings, and shifting sectoral dynamics are shaping the near-term outlook for Indian equities, according…
Read More » -
Is Pfizer Stock a “Value Trap” or a Generational Opportunity?
Key Points Pfizer’s stock has fallen more than 50% from its 2021 high. The stock is trading below its pre-coronavirus…
Read More » -
11 Most Undervalued Pharma Stocks to Invest In
In this article, we will be taking a look at the 11 Most Undervalued Pharma Stocks to Invest In. Haig…
Read More » -
Stocks to Watch for June 1: IndiGo, Glenmark Pharma, Lupin, NMDC, textile stocks and more
1 / 10 InterGlobe Aviation | IndiGo reported a net loss of ₹2,536.3 crore for the fourth quarter, compared with…
Read More » -
SMS Pharmaceuticals’ (NSE:SMSPHARMA) Earnings Are Of Questionable Quality
Investors were disappointed with SMS Pharmaceuticals Limited’s (NSE:SMSPHARMA) earnings, despite the strong profit numbers. Our analysis uncovered some concerning factors…
Read More »
